Abstract:Most adrenocortical tumors (ACTs) can be diagnosed directly by a combination of morphologic features and clinical findings. However, sometimes it may be difficult to distinguish ACTs from other neoplasms such as pheochromocytomas and some metastatic tumors, particularly for small biopsy specimens because they may be morphologically similar. Expression of calretinin has recently been suggested as a valuable immunomarker for the differential diagnosis between ACTs and other tumors; however, its diagnostic value is still under debate. To determine the diagnostic value of calretinin in Chinese patients with adrenocortical and non-ACTs, we employed both polyclonal and monoclonal anticalretinin to characterize the expression of calretinin in adrenal tissues and compared its expression with that of inhibin α, Melan-A, cytokeratin, or CD99 by immunohistochemistry in tissue microarrays and standard tissue sections of 414 specimens. Our results revealed that calretinin was expressed by adrenocortical cells, but not by the other cells tested and the percentage of calretinin-positive ACTs reached 99% when stained with polyclonal antibodies, which was higher than that with monoclonal anticalretinin (91.3%), anti-Melan-A (90.3%), antiinhibin α (81.6%). In addition, our results also revealed that ACTs were stained by cytokeratin (AE1/AE3) with variable degrees (58.7%). Furthermore, unlike anti-Melan-A that stained all metastatic malignant melanoma, anticalretinin did not recognize other tested tumors. Therefore, immunohistologic staining with polyclonal anticalretinin is more sensitive than other antibodies tested for the diagnosis of ACTs. However, monoclonal anticalretinin appeared to be more specific. Importantly, our data suggested that the fried-egg–like staining pattern, but not the mere cytoplasmic staining, was characteristic of anticalretinin staining in adrenocortical tissues. Notably, a few anticalretinin negative-ACTs were stained by other immunomarkers that we tested. Thus, the combinational characterization of calretinin (either by polyclonal or monoclonal antibody), inhibin α, and Melan-A expression is of great significance in the differential diagnosis of ACTs.

[The Expression of A103 and Inhibin Alpha in Adrenocortical Adenoma by High-Throughput Tissue Microarray Techniques].

[Diagnostic Value of A103 and Inhibin-Alpha in Adrenocortical Tumors: an Immunohistochemical Study Using Tissue Microarray Techniques].

Diagnostic Value of Immunohistochemical Markers in Tissue Microarray of Pheochromocytoma

Differential diagnosis of adrenal metastasis and lipid-poor adrenal adenoma with CT

Molecular Cluster Mining of Adrenocortical Carcinoma Via Multi-Omics Data Analysis Aids Precise Clinical Therapy.

Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas

Expression of STAT3 and IGF2 in Adrenocortical Carcinoma and Its Relationship with Angiogenesis.

Comparison of Immunohistochemical Markers in the Differential Diagnosis of Adrenocortical Tumors - Immunohistochemical Analysis of Adrenocortical Tumors

HPA-1 and VEGF Expression and Microvessel Density in Adrenocorticai Carcinoma

Expressions of multiple proteins in adrenal tumors and the clinical significance

Identification of immune-related biomarkers in adrenocortical carcinoma Immune-related biomarkers for ACC

Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma

Preliminary studies on the differential expression of adrenocorticotropic hormone receptor in adrenal adenomas.

Expressions of STAT 3,VEGF and MVD and the significance in adrenal cortical carcinoma

From clinic to mechanism: Proteomics-based assessment of angiogenesis in adrenal pheochromocytoma.

Neuroendocrinology of Adrenalcortical Tumors: a Primary Study

Identification of Key Genes and Related Drugs of Adrenocortical Carcinoma by Integrated Bioinformatics Analysis.

Relationship of IGF-2,VEGFR-2,PDGFR and HPA expressions in adrenal cortical carcinoma

Correlation of Hypoxia Inducible Factors, Vascular Endothelial Growth Factor Receptor 2, and Microvessel Density Expressions with Angiogenesis in Adrenocortical Tumours

The Role of Immunohistochemical Markers for the Diagnosis and Prognosis of Adrenocortical Neoplasms

Expression of Dab2 in different adrenocortical adenomas